A highly leukemogenic radiation leukemia virus isolate is a thymotropic, immunosuppressive retrovirus with a unique RNA structure
- PMID: 2435664
- DOI: 10.1002/ijc.2910390415
A highly leukemogenic radiation leukemia virus isolate is a thymotropic, immunosuppressive retrovirus with a unique RNA structure
Abstract
Clones of N-, B- and NB-fibrotropic viruses were isolated from weakly (D-RadLV) and strongly (A-RadLV) leukomogenic RadLV preparations. A highly leukemogenic, thymotropic virus (TV) was isolated by ex-vivo infection of thymocytes with A-RadLV. This virus could not be isolated from D-RadLV. Two-dimensional fingerprint analysis suggested that TV recombines unique RNA sequences with RNA genomic material derived from a B-tropic endogenous virus. C57BL/6 (B6) mice injected with B- or NB-fibrotropic clones, but not with TV or N-tropic viral clones, developed reactive T lymphocytes (Tr), capable of differentiating into anti-tumor cytotoxic cells. The N-tropic virus isolates were non-immunogenic in B6 mice whereas the TV isolate induced suppressor T lymphocytes (Ts) that abrogated a potential Tr response. These results suggest that emergence of highly leukemogenic RadLV involves activation of endogenous fibrotropic virus which is immunogenic in its natural host strain (B6). This virus can further recombine with other retroviral genetic sequences, resulting in a suppressogenic and thymotropic, highly leukemogenic virus.
Similar articles
-
Studies on emerging radiation leukemia virus variants in C57BL/Ka mice.J Virol. 1986 Apr;58(1):96-106. doi: 10.1128/JVI.58.1.96-106.1986. J Virol. 1986. PMID: 3005663 Free PMC article.
-
High- and low-leukemogenic variants of the radiation leukemia virus (RadLV): immunogenic, suppressive and genetic properties in relation to leukemogenic activity.Int J Cancer. 1984 Dec 15;34(6):875-82. doi: 10.1002/ijc.2910340621. Int J Cancer. 1984. PMID: 6439654
-
In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro.Proc Natl Acad Sci U S A. 1975 Sep;72(9):3546-50. doi: 10.1073/pnas.72.9.3546. Proc Natl Acad Sci U S A. 1975. PMID: 171665 Free PMC article.
-
In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.J Exp Med. 1980 Dec 1;152(6):1473-83. doi: 10.1084/jem.152.6.1473. J Exp Med. 1980. PMID: 6256461 Free PMC article.
-
A new immunobiological view of radiation-promoted lymphomagenesis.Int J Radiat Biol. 1997 Jan;71(1):81-94. doi: 10.1080/095530097144454. Int J Radiat Biol. 1997. PMID: 9020967 Review.
Cited by
-
Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):728-32. doi: 10.1073/pnas.89.2.728. Proc Natl Acad Sci U S A. 1992. PMID: 1731346 Free PMC article.
-
Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.Cancer Immunol Immunother. 1991;34(2):133-7. doi: 10.1007/BF01741348. Cancer Immunol Immunother. 1991. PMID: 1760817 Free PMC article.
-
Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.Cancer Immunol Immunother. 1995 Dec;41(6):389-96. doi: 10.1007/BF01526559. Cancer Immunol Immunother. 1995. PMID: 8635197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources